Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanofibrous-Composite Hydrogels for Modulating Stem Cell Behavior.

Cells, tissues, organs·2026
Same author

Design of High-Payload Silk/Butyrate Materials for Immunomodulation.

ACS macro letters·2026
Same author

Three-dimensional printing of bioengineered scaffolds to support skeletal muscle regeneration.

The Journal of physiology·2025
Same author

Lyophilized drug reservoir-integrated hydrogel-forming microarray patches for transdermal delivery of isoniazid and pyridoxine hydrochloride as a strategy to treat latent tuberculosis.

Annals of translational medicine·2025
Same author

Effects of Stiffness and Degradability on Cardiac Fibroblast Contractility and Extracellular Matrix Secretion in Three-Dimensional Hydrogel Scaffolds.

ACS biomaterials science & engineering·2025
Same author

Hydrogel Network Architecture Design Space: Impact on Mechanical and Viscoelastic Properties.

Gels (Basel, Switzerland)·2025

Related Experiment Video

Updated: Apr 15, 2026

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K

Nanoparticles as synthetic vaccines.

Josiah D Smith1, Logan D Morton1, Bret D Ulery1

  • 1Department of Chemical Engineering, University of Missouri, Columbia, MO 65211, United States.

Current Opinion in Biotechnology
|April 12, 2015
PubMed
Summary

Nanoparticles offer a promising approach to synthetic vaccines, enhancing immune responses diminished by epitope-based vaccines. These advanced delivery systems show potential for targeted delivery and adjuvant loading to improve vaccine efficacy.

More Related Videos

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.2K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

8.2K

Related Experiment Videos

Last Updated: Apr 15, 2026

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
11:07

Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination

Published on: April 29, 2015

13.8K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.2K
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
10:58

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

Published on: August 21, 2019

8.2K

Area of Science:

  • Biotechnology
  • Immunology
  • Materials Science

Background:

  • Modern vaccines utilize specific antigenic epitopes, reducing side effects but also diminishing immune responses.
  • Controlled release vehicles are explored to boost immunogenicity in synthetic vaccines.

Purpose of the Study:

  • To review recent advancements in using various nanoparticles as synthetic vaccines.
  • To highlight the capabilities of nanoparticles in enhancing vaccine delivery and immune activation.

Main Methods:

  • Review of current literature on inorganic, polymeric, and biomolecular nanoparticles in vaccine development.
  • Analysis of nanoparticle properties related to controlled release, targeting, and adjuvant loading.

Main Results:

  • Nanoparticles demonstrate effective controlled vaccine release.
  • Nanoparticles can be targeted to specific immune cells.
  • Nanoparticles can incorporate immunostimulatory adjuvants or possess inherent immune-activating properties.

Conclusions:

  • Nanoparticles represent a significant advancement in synthetic vaccine technology.
  • Their versatile properties offer solutions for enhancing the immunogenicity of modern vaccines.